Q9X variant of NFKBIA (NF-kappa-B inhibitor alpha)
Q9X in NFKBIA (NF-kappa-B inhibitor alpha) is a missense change. Clinical records from EBI and UniProt describe it as pathogenic. The record also includes structural context.
Q9X variant details
- rs886041411
- Pathogenic
- Missense
- EBI: ['pathogenic']
- UniProt: Pathogenic
- Structural context available